Salarius Pharmaceuticals Inc
General ticker "SLRX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.9M
Salarius Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -44.5%.
Estimated limits based on current volatility of 9.3%: low 1.31$, high 1.58$
Factors to consider:
- Current price 53.7% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [3.44$, 10.39$]
- 2024-12-30 to 2025-12-30 estimated range: [3.27$, 8.95$]
Financial Metrics affecting the SLRX estimates:
- Negative: Non-GAAP EPS, $ of -6.07 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -43.34 <= 2.35
- Positive: -0.25 < Return on assets ratio (scaled to [-100,100]) of -0.19
Short-term SLRX quotes
Long-term SLRX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $1.84MM | $0.00MM | $0.00MM |
| Operating Expenses | $14.65MM | $31.84MM | $0.01MM |
| Operating Income | $-12.81MM | $-31.84MM | $-0.01MM |
| Non-Operating Income | $0.04MM | $0.23MM | $0.00MM |
| R&D Expense | $8.55MM | $15.84MM | $0.01MM |
| Income(Loss) | $-12.77MM | $-31.61MM | $-0.01MM |
| Profit(Loss) | $-12.77MM | $-31.61MM | $-0.01MM |
| Stockholders Equity | $38.72MM | $10.38MM | $5.29MM |
| Inventory | $0.00MM | $1.61MM | $0.00MM |
| Assets | $40.83MM | $14.65MM | $6.59MM |
| Operating Cash Flow | $-10.20MM | $-17.60MM | $-12.85MM |
| Capital expenditure | $0.00MM | $1.50MM | $0.00MM |
| Investing Cash Flow | $0.00MM | $-1.50MM | $0.00MM |
| Financing Cash Flow | $28.30MM | $1.99MM | $6.64MM |
| Earnings Per Share* | $-7.68 | $-14.77 | $-0.00 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.